Advisory Alpha, LLC Abb Vie Inc. Transaction History

Advisory Alpha, LLC

$2.78 Billion
Q3 2024

A detailed history of Advisory Alpha, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisory Alpha, LLC holds 4,193 shares of ABBV stock, worth $754,740. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,193

Previous 4,063 3.2%

Holding current value

$754,740

Previous $696,000 18.97%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $21,299 - $25,912	130 Added 3.2%	4,193 $828,000
Q2 2024 Aug 21, 2024	SELL	$154.79 - $180.76 $3,405 - $3,976	-22 Reduced 0.54%	4,063 $696,000
Q1 2024 May 06, 2024	BUY	$159.82 - $182.1 $66,325 - $75,571	415 Added 11.31%	4,085 $743,000
Q4 2023 Jan 23, 2024	BUY	$137.6 - $154.97 $142,966 - $161,013	1,039 Added 39.49%	3,670 $568,000
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $71,470 - $82,737	-535 Reduced 16.9%	2,631 $392,000
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $3,312 - $4,122	-25 Reduced 0.78%	3,166 $426,000
Q1 2023 May 02, 2023	SELL	$144.61 - $166.54 $260,153 - $299,605	-1,799 Reduced 36.05%	3,191 $508,000
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $180,494 - $216,460	-1,305 Reduced 20.73%	4,990 $806,000
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $3,086 - $3,540	23 Added 0.37%	6,295 $845,000
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $12,385 - $15,746	90 Added 1.46%	6,272 $961,000
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $130,132 - $161,457	986 Added 18.98%	6,182 $1 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $90,026 - $113,909	838 Added 19.23%	5,196 $704,000
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $97,249 - $110,392	914 Added 26.54%	4,358 $470,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $362,343 - $403,671	3,444 New	3,444 $388,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $122,022 - $164,743	-1,516 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $120,188 - $141,061	-1,399 Reduced 47.99%	1,516 $784,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $67,647 - $90,521	-922 Reduced 24.03%	2,915 $278,000
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $80,883 - $122,628	-1,254 Reduced 24.63%	3,837 $315 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $161,499 - $202,069	2,239 Added 78.51%	5,091 $451 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $179,618 - $215,953	2,852 New	2,852 $215,000
Q2 2019 Aug 16, 2019	SELL	$65.7 - $83.98 $174,433 - $222,966	-2,655 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $7,482 - $8,806	-97 Reduced 3.52%	2,655 $0
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $214,243 - $264,219	2,752 New	2,752 $220,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.

Account

Advisory Alpha, LLC Abb Vie Inc. Transaction History